Post by
Bullknit101 on Sep 22, 2021 11:39pm
The Dales Report
The whole rare cannabinoid maufacturing space is turning the corner. While Willow works on CBG, InMed is selling CBC with THCV and CBDV to follow soon: https://youtu.be/i7nlfnWlpPs
Comment by
lscfa on Sep 23, 2021 12:59am
With some cannabis strains now reaching 20% CBD why is Willow even pursuing that market. It should be focused on other ingredients like CBG which are only present in trace amounts in the plant.
Comment by
Scotty007 on Sep 24, 2021 10:18am
Ummmm..., they are pursuing CBG - and selling it. Also currently, CBGA CBGV THCV CBDV